Research - PCDH19 female epilepsy is associated with low levels of allopregnanolone in the blood, a neurosteroid, hormone metabolite, and a positive allosteric modulator of the GABAa receptor.
PremiumInsights - Horizon Pharma (HZNP) has gone hostile in its attempt to acquire Depomed (DEPO), offering $29.25 in HZNP stock, or $3 billion, for the smaller specialty … Continue Reading
Read nowResearch - Investors who were involved for the now-failed Alzheimer’s program are vacating the stock. That’s an opportunity for new investors, like us, looking further down the road to what could be a compelling and novel diabetes treatment.
PremiumInsights - It’s one of the most elusive events in biotech: the liquidation. But after a trial failure of epic proportions – and a collapse in its stock … Continue Reading
Read nowInsights - Two drugs directed at behavioral disorders failed mid-stage studies on Wednesday morning, said sponsors Alcobra (ADHD) and Transition Therapeutics (TTHI), yet again highlighting the difficulty in developing drugs for disorders involving the Central Nervous System.
Read nowResearch - Biotech is finally breaking out to new all-time highs, and you’ll be hard-pressed to find much red on your watch-list. We wrote about the current … Continue Reading
Read nowResearch - Synergy Pharmaceuticals (SGYP) reported positive data from the first of two phase 3 trials for its constipation drug plecanatide on Wednesday.
Read now
